Ariad Pharmaceuticals Inc fka ARIA

[zuize]

This piece of news release is inaccurate for Pierre is no longer with Ariad many months ago.

According to Pierre's linkedIn page he left Ariad in November last year and started working at Alacrita Consulting firm (Alacrita, LLC.) since then:
Pierre Dodion's LinkedIn page

He was one of those 160 employees gone after the flash crash, but they made it sound like the guys is leaving a sinking ship for greener pasture.

Marseille, September 16, 2014
Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer and inflammatory diseases, today announces the nomination of Pierre Dodion as Chief Medical Officer (CMO) and member of the Executive committee.
....
In 2007, Pierre Dodion joined ARIAD Pharmaceuticals (ARIA), first as SVP and Chief Medical Officer, then as SVP Corporate Development and Operations. He played a major role in the expansion of ARIAD, notably in Europe. He contributed to two development programs in oncology: ridaforolimus (licensed to Merck) and ponatinib (marketed by ARIAD Pharmaceuticals as Iclusig®).